1. P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL. (23rd June 2022) Authors: Thomopoulos, T.; Bouchla, A.; Antoniadou, A.; Terpos, E.; Politou, M.; Stamoulis, K.; Koromboki, E.; Papageorgiou, S.; Kotanidou, A.; Kalomenidis, I.; Jahaj, E.; Grigoropoulou, S.; Pagoni, M.; Grouzi, E.; Poulakou, G.; Trontzas, I.; Labropoulou, S.; Mentis, A.; Bamias, A.; Tsiodras, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-17 Mesothelioma: a retrospective study of thromboembolism events. Issue 200 (April 2021) Authors: Dimakakos, E.; Basdeki, K.; Gkiozos, I.; Tsagkouli, S.; Rovina, N.; Mpakakos, P.; Ptohis, N.; Trontzas, I.; Kotteas, E.; Syrigos, K. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗